Improvement of lipid profile by probiotic/protective cultures: Study in a non-carcinogenic small intestinal cell model

New Microbiologica

Volumn 37, Issue 1, 2014, Pages 51-64

  Gorenjak, Mario ^a   Gradišnik, Lidija ^a   Trapečar, Martin ^a   Pistello, Mauro ^b   Kozmus, Carina Pinto ^c   Škorjanc, Dejan ^a   Skok, Pavel ^d   Langerholc, Tomaž ^a   Cencič, Avrelija ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

ABCG5; ABCG8; Lactobacillus plantarum; Liver X receptors; LPL; NPC1L1

Indexed keywords

CHOLESTEROL; PROBIOTIC AGENT; PROTEIN;

ARTICLE; BIOLOGICAL MODEL; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LACTOBACILLUS PLANTARUM; METABOLISM; MICROBIOLOGY; SMALL INTESTINE;

CHOLESTEROL; GENE EXPRESSION; HUMANS; INTESTINE, SMALL; LACTOBACILLUS PLANTARUM; MODELS, BIOLOGICAL; PROBIOTICS; PROTEINS;

EID: 84894193702     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., Iyer S.P., Maguire M., Golovko A., Zeng M., Wang L., Murgolo N., Graziano M.P. (2004). Niemann-pick c1 like 1 protein is critical for intestinal cholesterol absorption. Sci. 303, 1201-1204.
2. Armstrong M.L., Warner E.D., Connor W.E. (1970). Regression of coronary atheromatosis in rhesus monkeys. Circ. Res. 27, 59-67.
3. Beaulieu J.F. (1997). Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Prog. Histochem. Cytochem. 31, 1-78.
4. Beaulieu J.F. (1999). Integrins and human intestinal cell functions. Front. Biosci. 4, D310-321.
5. Begley M., Hill C., Gahan C.G.M. (2006). Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72, 1729-1738.
6. Belanger I., Beaulieu J.F. (2000). Tenascin in the developing and adult human intestine. Histol. Histopathol. 15, 577-585.
7. Bergamini A., Perno C.F., Capozzi M., Mannella E., Salanitro A., Calio R., Rocchi G. (1992). A tetrazolium- based colorimetric assay for quantification of hiv-1-induced cytopathogenicity in monocytemacrophages exposed to macrophage-colonystimulating factor. J. Virol. Methods. 40, 275-286.
8. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H.H. (2000). Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent abc transporters. Sci. 290, 1771-1775.
9. Brooks S.A., Carter T.M., Royle L., Harvey D.J., Fry S.A., Kinch C., Dwek R.A., RUDD P.M. (2008). Altered glycosylation of proteins in cancer: What is the potential for new anti-tumour strategies. Anticancer Agents Med. Chem. 8, 2-21.
10. Carlson S.A., Omary M.B., Jones B.D. (2002). Identification of cytokeratins as accessory mediators of salmonella entry into eukaryotic cells. Life Sci. 70, 1415-1426.
11. Cencic A., Langerholc T. (2010). Functional cell models of the gut and their applications in food microbiology - a review. Int. J. Food Microbiol. 141, S4-S14.
12. Connor W.E. (1961). Dietary cholestrol and the pathogenesis of atherosclerosis. Geriatrics. 16, 407-415.
13. Dashkevicz M.P., Feighner S.D. (1989). Development of a differential medium for bile salt hydrolaseactive lactobacillus spp. Appl. Environ. Microbiol. 55, 11-16.
14. Davis H.R., JR., Hoos L.M., Tetzloff G., Maguire M., Zhu L.J., Graziano M.P., Altmann S.W. (2007). Deficiency of niemann-pick c1 like 1 prevents atherosclerosis in apoe-/- mice. Arterioscler. Thromb. Vac. Biol. 27, 841-849.
15. Davis H.R., JR., Zhu L.J., Hoos L.M., Tetzloff G., Maguire M., Liu J., Yao X., Iyer S.P., Lam M.H., Lund E.G., Detmers P.A., Graziano M.P., Altmann S.W. (2004). Niemann-pick c1 like 1 (npc1l1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J. Biol. Chem. 279, 33586-33592.
16. Duval C., Touche V., Tailleux A., Fruchart J.C., Fievet C., Clavey V., Staels B., Lestavel S. (2006). Niemann- pick c1 like 1 gene expression is down-regulated by lxr activators in the intestine. Biochem. Biophys. Res. Commun. 340, 1259-1263.
17. Edwards P.A., Kennedy M.A., Mak P.A. (2002). Lxrs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vasc. Pharmacol. 38, 249-256.
18. Geddes K., Philpott D.J. (2008). A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology. 135, 8-12.
19. Gibson U.E., Heid C.A., Williams P.M. (1996). A novel method for real time quantitative rt-pcr. Genome Res. 6, 995-1001.
20. Gilliland S.E., Staley T.E., Bush L.J. (1984). Importance of bile tolerance of lactobacillus acidophilus used as a dietary adjunct. J. Dairy Sci. 67, 3045-3051.
21. Gorenjak M., Skok P., Cencic A. (2012a). Novel promising functional cell models to study molecular events in metabolic syndrome. Nutr. Ther. Metab. 30, 34-41.
22. Gorenjak M., Trapecar M., Gradisnik L., skok P., Cencic A. (2012b). A novel polymerase chain reaction (pcr) based assay for authentication of cell lines or tissues from human, pig and chicken origin. J. Biosci. Biotechnol. 1, 1-7.
23. Hakomori S. (1996). Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309-5318.
24. Hazard S.E., Patel S.B. (2007). Sterolins abcg5 and abcg8: Regulators of whole body dietary sterols. Pflugers Arch. 453, 745-752.
25. Huang Y., Zheng Y. (2010). The probiotic lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of niemann-pick c1-like 1 in caco-2 cells. Br. J. Nutr. 103, 473.
26. Ignatowski A. (1908). Influence of animal food on the organism of rabbits. Izvest Imp. Voyenno-Med. Akad. 16, 154.
27. Ivec M., Botic' T., Koren S., Jakobsen M., Weingartl H., Cencič A. (2007). Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Res. 75, 266-274.
28. Jagannathan S.N., Connor W.E., Baker W.H., Bhattacharyya A.K. (1974). The turnover of cholesterol in human atherosclerotic arteries. J. Clin. Invest. 54, 366-377.
29. Kimoto H., Mizumachi K., Nomura M., Kobayashi M., Fujita Y., Okamoto T., Suzuki I., Tsuji N.M., Kurisaki J., Ohomomo S. (2007). Lactococcus sp. As potential probiotic lactic acid bacteria. Japan Agr. Res. Quart. 41, 181-189.
30. Klaver F.A., Van Der Meer R. (1993). The assumed assimilation of cholesterol by lactobacilli and bifidobacterium bifidum is due to their bile saltdeconjugatingactivity. Appl. Environ. Microbiol. 59, 1120-1124.
31. Larosa J.C., Hunninghake D., Bush D., Criqui M.H., Getz G.S., Gotto A.M., JR., Grundy S.M., Rakita L., Robertson R.M., Weisfeldt M.L., et al. (1990). The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the american heart association and the national heart, lung, and blood institute. The task force on cholesterol issues, american heart association. Circulation. 81, 1721-1733.
32. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakuma N., Pegoraro R., SRivastava A.K., Salen G., Dean M., Patel S.B. (2001). Identification of a gene, abcg5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27, 79-83.
33. Liong M.T., Shah N.P. (2005). Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 88, 55-66.
34. Livak K.J., Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods. 25, 402-408.
35. Lussier C., Basora N., Bouatrouss Y., Beaulieu J.F. (2000). Integrins as mediators of epithelial cellmatrix interactions in the human small intestinal mucosa. Microsc. Res. Tech. 51, 169-178.
36. Lye H.-S., Kuan C.-Y., Ewe J.-A., FUng W.-Y., Liong M.-T. (2009). The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int. J. Mol. Sci. 10, 3755-3775.
37. Mann G.V. (1974). Studies of a surfactant and cholesteremia in the maasai. Am. J. Clin. Nutr. 27, 464-469.
38. Manson J.E., Tosteson H., Ridker P.M., Satterfield S., Hebert P., O'Connor G.T., Buring J.E., Hennekens C.H. (1992). The primary prevention of myocardial infarction. N. Engl. J. Med. 326, 1406-1416.
39. Mathara J.M., Schillinger U., Guigas C., Franz C., Kutima P.M., Mbugua S.K., Shin H.K., Holzapfel W.H. (2008). Functional characteristics of lactobacillus spp. From traditional maasai fermented milk products in kenya. Int. J. Food Microbiol. 126, 57-64.
40. Mcauliffe O., Cano R.J., Klaenhammer T.R. (2005). Genetic analysis of two bile salt hydrolase activities in lactobacillus acidophilus ncfm. Appl. Environ. Microbiol. 71, 4925-4929.
41. Mehta R., Birerdinc A., Hossain N., Afendy A., Chandhoke V., Younossi Z., Baranova A. (2010). Validation of endogenous reference genes for qrt-pcr analysis of human visceral adipose samples. BMC Mol. Biol. 11, 39.
42. Mieg D.T., Mieg J.T. (2006). Aceview: a comprehensive cdna-supported gene and transcripts annotation. Genome Biol. 7, S12-S12.14.
43. Miura S., Saku K. (2008). Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern. Med. 47, 1165-1170.
44. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55-63.
45. NCEP. (1988). Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch. Intern. Med. 148, 36-69.
46. Niho N., Mutoh M., Takahashi M., Tsutsumi K., Sugimura T., Wakabayashi K. (2005). Concurrent suppression of hyperlipidemia and intestinal polyp formation by no-1886, increasing lipoprotein lipase activity in min mice. Proc. Natl. Acad. Sci. U. S. A. 102, 2970-2974.
47. Nissen L., Chingwaru W., Sgorbati B., Biavati B., Cencic A. (2009). Gut health promoting activity of new putative probiotic/protective lactobacillus spp. Strains: A functional study in the small in testinal cell model. Int. J. Food Microbiol. 135, 288-294.
48. Noh D.O., Kim S.H., Gilliland S.E. (1997). Incorporation of cholesterol into the cellular membrane of lactobacillus acidophilus atcc 43121. J. Dairy Sci. 80, 3107-3113.
49. Nomiyama T., Bruemmer D. (2008). Liver x receptors as therapeutic targets in metabolism and atherosclerosis. Curr. Atheroscler. Rep. 10, 88-95.
50. Ooi L.-G., Liong M.-T. (2010). Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int. J. Mol. Sci. 11, 2499-2522.
51. Pageot L.P., Perreault N., Basora N., Francoeur C., Magny P., Beaulieu J.F. (2000). Human cell models to study small intestinal functions: recapitulation of the crypt-villus axis. Microsc. Res. Tech. 49, 394-406.
52. Patel A.K., Singhania R.R., Pandey A., Chincholkar S.B. (2009). Probiotic bile salt hydrolase: Current developments and perspectives. Appl. Biochem. Biotechnol. 162, 166-180.
53. Pereira D.I.A., Gibson G.R. (2002). Cholesterol assimilationby lactic acid bacteria and bifidobacteria isolated from the human gut. Appl. Environ. Microbiol. 68, 4689-4693.
54. Radonic' A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. (2004). Guideline to reference gene selection for quantitative real-time pcr. Biochem. Biophys. Res. Commun. 313, 856-862.
55. Razin S. (1975). Cholesterol incorporation into bacterial membranes. J. Bacteriol. 124, 570-572.
56. Repa J.J. (2002). Regulation of atp-binding cassette sterol transporters abcg5 and abcg8 by the liver x receptors alpha and beta. J. Biol. Chem. 277, 18793-18800.
57. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., Mangelsdorf D.J. (2000). Regulation of absorption and abc1-mediated efflux of cholesterol by rxr heterodimers. Sci. 289, 1524-1529.
58. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. (2005). The caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on caco-2 cell functional characteristics. Cell Biol. Toxicol. 21, 1-26.
59. Sanders M.E. (2000). Considerations for use of probiotic bacteria to modulate human health. J. Nutr. 130, 384S-390S.
60. Saotome K., Morita H., Umeda M. (1989). Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs. Toxicol. in vitro. 3, 317-321.
61. Shibasaki M., Bujo H., Takahashi K., Murakami K., Unoki H., Saito Y. (2006). Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice. Horm. Metab. Res. 38, 491-496.
62. Shimada M., Shimano H., Gotoda T., Yamamoto K., Kawamura M., Inaba T., Yazaki Y., Yamada N. (1993). Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J. Biol. Chem. 268, 17924-17929.
63. Stamler J., Shekelle R. (1988). Dietary cholesterol and human coronary heart disease. The epidemiologic evidence. Arch. Pathol. Lab. Med. 112, 1032-1040.
64. Tani H., Sato M., Tsuchiya H., Namikawa I. (1993). Cholesterol incorporation into bacillus megaterium without compositional modification of membrane lipids in response to changes of the membrane functions. Curr. Microbiol. 26, 253-256.
65. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. (2002). Accurate normalization of real-time quantitative rt-pcr data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
66. Wilson M.D., Rudel L.L. (1994). Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid Res. 35, 943-955.
67. Wood S.R., Zhao Q., Smith L.H., Daniels C.K. (2003). Altered morphology in cultured rat intestinal epithelial iec-6 cells is associated with alkaline phosphatase expression. Tissue Cell. 35, 47-58.
68. Yagyu H., Ishibashi S., Chen Z., Osuga J., Okazaki M., Perrey S., Kitamine T., Shimada M., Ohashi K., Harada K., Shionoiri F., Yahagi N., Gotoda T., Yazaki Y., Yamada N. (1999). Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein e knockout mice. J. Lipid Res. 40, 1677-1685.
69. Yoon H., Ju J., Kim H., Lee J., Park H., Ji Y., Shin H., Do M.S., Lee J.M., Holzapfel W. (2011). Lactobacillus rhamnosus bfe 5264 and lactobacillus plantarum nr74 promote cholesterol excretion through the up-regulation of abcg5/8 in caco-2 cells. Probiotics & Antimicro. Prot. 3, 194-203.
70. Yu L. (2002). Overexpression of abcg5 and abcg8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110, 671-680.
71. Yu L. (2004). Expression of abcg5 and abcg8 is required for regulation of biliary cholesterol secretion. J. Biol. Chem. 280, 8742-8747.
72. Yu L., York J., Von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. (2003). Stimulation of cholesterol excretion by the liver x receptor agonist requires atp-binding cassette transporters g5 and g8. J. Biol. Chem. 278, 15565-15570.
73. Zabaneh D., Balding D.J. (2010). A genome-wide association study of the metabolic syndrome in indian asian men. Plos One. 5, e11961.
74. Zhang Y. (2001). Regulation of lipoprotein lipase by the oxysterol receptors, lxralpha and lxrbeta. J. Biol. Chem. 276, 43018-43024.